Table 1 Baseline characteristics of study participants
Variables | RT (n = 38) | RT + flumazenil (n = 38) | Propofol (n = 38) | P value |
|---|---|---|---|---|
Age (y) | Â | Â | Â | Â |
 Mean ± SD | 43.5 ± 15.6 | 44.7 ± 16.8 | 44.3 ± 18.1 | 0.951 |
 ≥ 65 | 6(15.8) | 7(18.4) | 7(18.4) | 0.941 |
Male | 14(36.8) | 22(57.9) | 19(50.0) | 0.179 |
Weight (kg) | 63.6 ± 12.6 | 66.6 ± 11.3 | 65.9 ± 13.5 | 0.540 |
Height (cm) | 166.7 ± 8.6 | 168.7 ± 7.8 | 168.1 ± 9.1 | 0.568 |
BMI (kg/m2) | 22.7 ± 3.4 | 23.3 ± 3.3 | 23.2 ± 3.7 | 0.729 |
ASA physical status | Â | Â | Â | 0.868 |
 I | 17(44.7) | 17(44.7) | 19(50.0) |  |
 II | 21(55.3) | 21(55.3) | 19(50.0) |  |
Comorbid medical conditions | Â | Â | Â | Â |
 Hypertension | 10(26.3) | 10(26.3) | 5(13.2) | 0.278 |
 Diabetes | 5(13.2) | 1(2.6) | 2(5.3) | 0.270 |
 Coronary heart disease | 1(2.6) | 0(0.0) | 1(2.6) | 1.000 |
 Thyroid disease | 3(7.9) | 1(2.6) | 2(5.3) | 0.870 |
 Arrhythmia | 4(10.5) | 4(10.5) | 4(10.5) | 1.000 |
Surgery type | Â | Â | Â | 0.112 |
 Urology | 14(36.8) | 24(63.2) | 20(52.6) |  |
 Obstetrics and Gynecology | 16(42.1) | 8(21.1) | 7(18.4) |  |
 General surgery | 7(18.4) | 6(15.8) | 10(26.3) |  |
 Thoracic surgery | 1(2.6) | 0(0.0) | 1(2.6) |  |
Preoperative laboratory tests | Â | Â | Â | Â |
 Neutrophil / lymphocyte ratio, % | 2.07(1.57–2.68) | 2.26(1.81–3.52) | 2.28(1.76-3) | 0.212 |
 Platelet / lymphocyte ratio, % | 115.47(106.40-147.97) | 133.93(109.89-165.58) | 138.99(105.92-164.67) | 0.371 |
 ALT (U/L) | 13.50 (9.00-20.25) | 14.00 (12.00-18.25) | 15.00 (10.00-22.75) | 0.663 |
 Urea (mmol/L) | 4.80 (4.20–6.25) | 5.35 (4.38–6.62) | 4.80 (4.23–5.38) | 0.269 |
 TBIL (µmol/L) | 8.55 (5.78–12.28) | 10.80 (8.90–12.80) | 10.05 (7.62–12.47) | 0.222 |
 Duration of surgery (min) | 42.2 ± 27.7 | 38.6 ± 29.1 | 38.7 ± 25.1 | 0.767 |